Teva Asthma Predictive Analytics Study

计划入组 100 人 · 首次发布于 2021 年 8 月 9 日

Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration

计划入组 39 人 · 首次发布于 2024 年 2 月 28 日

Efficacy and Safety of BCD-063 and Copaxone-Teva in Patients With Relapsing-Remitting Multiple Sclerosis

计划入组 158 人 · 首次发布于 2016 年 4 月 27 日

Synthetic conjugated estrogen(Teva)

Denosumab biosimilar(Teva Pharma)

Ethylaminobenzylmethylcarbonyl Group

C₁₇H₂₄N₂O₃

Teva Pharma B.V.

Netherlands

Teva GmbH

Germany

TEVA NEUROSCIENCE, INC.

United States

Amneal Receives FDA Tentative Approval for Generic Asthma Inhaler, Targeting $329M Market

Formycon AG Secures €650M Biosimilar Partnership with ATHOS KG in Landmark Deal

Teva's TEV-'749 Demonstrates Improved Social Functioning in Schizophrenia Patients